Myocardium

Publication Title: 
The Cochrane Database of Systematic Reviews

BACKGROUND: Influenza is a highly infectious viral disease that is particularly common in the winter months. Oscillococcinum® is a patented homeopathic medicine that is made from a 1% solution of wild duck heart and liver extract, which is then serially diluted 200 times with water and alcohol. OBJECTIVES: To determine whether homeopathic Oscillococcinum® is more effective than placebo in the prevention and/or treatment of influenza and influenza-like illness in adults or children.

Author(s): 
Mathie, Robert T.
Frye, Joyce
Fisher, Peter
Publication Title: 
Annali dell'Istituto Superiore Di Sanita

The use of a complementary medicine approach, and specifically of the popular medicine Oscillococcinum, for the treatment of influenza-like syndromes remains controversial. This brief paper analyses the currently available literature on this homeopathic preparation and the Cochrane Collaboration's 2006 systematic review, along with other recent studies, in order to clarify certain fundamental aspects of its use in the treatment of influenza.

Author(s): 
Marrari, Luigi Alberto
Terzan, Laurence
Chaufferin, Gilles
Publication Title: 
International Journal of Cardiology

The effect of orally administered indigenous drugs Terminalia arjuna, T. belerica and T. chebula were investigated on experimental atherosclerosis. Rabbits were fed a cholesterol-rich diet to induce atherosclerosis. The three drugs were fed along with cholesterol. At the end of the experimental period the animals were killed and their plasma and tissue lipid components estimated. Atherosclerotic lesions of the aorta were examined histologically. T. arjuna was found to be the most potent hypolipidemic agent and induced partial inhibition of rabbit atheroma. The results indicate that T.

Author(s): 
Shaila, H. P.
Udupa, S. L.
Udupa, A. L.
Publication Title: 
Mutation Research

During the course of normal respiration, reactive oxygen species are produced which are particularly detrimental to mitochondrial function. This is shown by recent studies with a mouse that lacks the mitochondrial form of superoxide dismutase (Sod2). Tissues that are heavily dependent on mitochondrial function such as the brain and heart are most severely affected in the Sod2 mutant mouse.

Author(s): 
Melov, S.
Coskun, P. E.
Wallace, D. C.
Publication Title: 
Clinical and Experimental Pharmacology & Physiology

SUMMARY: The contractile function of the heart requires the release of Ca(2+) from intracellular Ca(2+) stores in the sarcoplasmic reticulum (SR) of cardiac muscle cells. The efficacy of Ca(2+) release depends on the amount of Ca(2+) loaded into the Ca(2+) store and the way in which this 'Ca(2+) load' influences the activity of the cardiac ryanodine receptor Ca(2+) release channel (RyR2).

Author(s): 
Dulhunty, Angela F.
Wium, Elize
Li, Linwei
Hanna, Amy D.
Mirza, Shamaruh
Talukder, Sadik
Ghazali, Nuur Aa
Beard, Nicole A.
Publication Title: 
Disease Models & Mechanisms

Cardiac fibrosis is critically involved in the adverse remodeling accompanying dilated cardiomyopathies (DCMs), which leads to cardiac dysfunction and heart failure (HF). Connective tissue growth factor (CTGF), a profibrotic cytokine, plays a key role in this deleterious process. Some beneficial effects of IGF1 on cardiomyopathy have been described, but its potential role in improving DCM is less well characterized.

Author(s): 
Touvron, Melissa
Escoubet, Brigitte
Mericskay, Mathias
Angelini, Aude
Lamotte, Luciane
Santini, Maria Paola
Rosenthal, Nadia
Daegelen, Dominique
Tuil, David
Decaux, Jean-FranÁois
Publication Title: 
Journal of Cardiovascular Translational Research

The extracellular matrix (ECM) provides structural support by serving as a scaffold for cells, and as such the ECM maintains normal tissue homeostasis and mediates the repair response following injury. In response to myocardial infarction (MI), ECM expression is generally upregulated in the left ventricle (LV), which regulates LV remodeling by modulating scar formation. The ECM directly affects scar formation by regulating growth factor release and cell adhesion and indirectly affects scar formation by regulating the inflammatory, angiogenic, and fibroblast responses.

Author(s): 
Ma, Yonggang
Halade, Ganesh V.
Lindsey, Merry L.
Publication Title: 
Laboratory Investigation; a Journal of Technical Methods and Pathology

The protective effect of heme oxygenase-1 (HO-1) expression in cardiovascular disease has been previously demonstrated using transgenic animal models in which HO-1 is constitutively overexpressed in the heart. However, the temporal requirements for protection by HO-1 induction relative to injury have not been investigated, but are essential to employ HO-1 as a therapeutic strategy in human cardiovascular disease states.

Author(s): 
Hull, Travis D.
Bolisetty, Subhashini
DeAlmeida, Angela C.
Litovsky, Silvio H.
Prabhu, Sumanth D.
Agarwal, Anupam
George, James F.
Publication Title: 
Psychiatric Research Reports
Author(s): 
Shock, N. W.
Publication Title: 
Experimental Gerontology

Chronic caloric restriction (CR) has been demonstrated to increase longevity in lower species and studies are ongoing to evaluate its effect in higher species. A consistent metabolic feature of CR is improved insulin sensitivity and lowered lifetime glycemia, yet the mechanism responsible is currently unknown. However, the membrane's physiochemical properties, as determined by phospholipid composition, have been related to insulin action in animal and human studies and CR has been reported to alter membrane lipid content.

Author(s): 
Cefalu, W. T.
Wang, Z. Q.
Bell-Farrow, A. D.
Terry, J. G.
Sonntag, W.
Waite, M.
Parks, J.

Pages

Subscribe to RSS - Myocardium